Press
-

Mary Lanier talks about SRI Biosciences’ response to the ongoing COVID-19 pandemic
Mary Lanier is a Research Scientist at SRI Biosciences in Menlo Park, CA. Join us to learn how SRI Biosciences is responding to the COVID-19 pandemic—from using existing drug discovery and delivery platforms to innovate vaccines and treatment, to rapid testing capabilities, to developing new vaccines that could protect against future viruses. Learn more about…
-

Ann Garnier talks about Lisa Health
Ann Garnier is the Founder and CEO of Lisa Health, an SRI Ventures spinoff company. Join us to learn how Lisa Health is transforming menopause and midlife women’s health using the power of technology fused with evidence-based medicine and community. They provide data-driven, science-backed insights and therapeutics to support women across their 30-year midlife journey…
-

Shari Golan talks about SRI Education
Shari Golan is the President of SRI Education in Menlo Park, CA. Join us as she explains how SRI Education works to reduce barriers, optimize outcomes, and ensure educational equity for all children, youth, and families by conducting high-quality research and evaluation of education programs and interventions, supporting use of data and evidence through training,…
-

Cryogenic advances a must for quantum technology applications
Identifying the four priorities for cryogenic technologies that will expedite the transformation of QIST from a research-focused realm to commercial deployment







